Trillium Therapeutics

+$0.20 (+2.31%) Today
+$0.01 (+0.06%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell TRIL and other stocks, options, and ETFs commission-free!

About TRIL

Trillium Therapeutics Inc. Common Shares, also called Trillium Therapeutics, is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer.

CEO
Jan Skvarka
Employees
—
Headquarters
Mississauga, Ontario
Founded
2004

TRIL Key Statistics

Market Cap
962.90M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.34M
High Today
$8.77
Low Today
$8.43
Open Price
$8.50
Volume
667.79K
52 Week High
$20.96
52 Week Low
$5.66

TRIL Earnings

-$1.07
-$0.22
$0.64
$1.49
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.90 per share
Actual
-$0.11 per share

You May Also Like

NBA+
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure